Travis Besanger

Travis Besanger is a seasoned expert in the field of medical isotopes and pharmaceuticals, currently serving as Vice President of Medical Isotopes at Kinectrics since February 2019, after holding the position of Technical and Business Director. Prior to this role, Travis was the President of NuGeneris Specialty Pharmaceuticals, a subsidiary of CPDC focusing on therapeutic radiopharmaceuticals. Extensive experience at CPDC includes serving as Chief Business Officer and Executive Director of Business Development from October 2008 to February 2019. Additionally, Travis was Head of Business Development at ARTMS, a company known for developing technologies for the production of technetium-99m. Earlier in the career, Travis worked as Scientist III in Process Development at Molecular Insight Pharmaceuticals. Academic qualifications include a PhD in Analytical Chemistry from McMaster University and a Bachelor of Science in Chemistry and Biochemistry from the University of Saskatchewan.